We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Innova and Mologic Sign Supply and Licensing Agreement

News   Aug 05, 2015

 
Innova and Mologic Sign Supply and Licensing Agreement
 
 
Advertisement
 

RELATED ARTICLES

A Mirror-image Peptide Tumor Treatment

News

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

READ MORE

Next-generation Triple Antibody Test for COVID-19 Given Green Light by MHRA

News

Scientists have developed and received MHRA approval for a new device that could allow health professionals to test patients’ antibody response to COVID-19 in as little as seven minutes.

READ MORE

Accelerated Discovery of Bioactive Components in Seaweed

News

Using state-of-the-art approaches coupled with bio- and cheminformatics and machine learning, researchers at the GEOMAR Helmholtz Centre for Ocean Research Kiel have succeeded in discovering new, bioactive components of the Baltic Sea seaweed Fucus vesiculosus and its fungal symbiont against infectious bacteria or skin cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE